| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10307918 | Schizophrenia Research | 2016 | 9 Pages |
Abstract
Although limited by the small sample size, our findings suggest that patients who show a favorable response and full and enduring symptom remission during antipsychotic treatment, as well as those with marked deterioration despite MT should rather be recommended to remain on treatment because they are at higher risk for symptom re-exacerbation after (stepwise) drug discontinuation.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Wolfgang Gaebel, Mathias Riesbeck, Wolfgang Wölwer, Ansgar Klimke, Matthias Eickhoff, Martina von Wilmsdorff, Walter de Millas, Wolfgang Maier, Stephan Ruhrmann, Peter Falkai, Heinrich Sauer, Andrea Schmitt, Michael Riedel, Stefan Klingberg,